RecruitingAortic Arch DissectionAortic Arch Aneurysm
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Eligible age
18+ yrs
Accepts
All genders
Locations
12 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Sponsor: W.L.Gore & Associates
You may qualify if…
- ✓ 1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements.
- ✓ 2. Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1.
- ✓ 3. Patient is age ≥ 18 years at time of informed consent signature.
You may not qualify if…
- ✕ 1. Patient who is, at the time of consent, unlikely to be available for defined follow-up visits.
- ✕ 2. Patient with exclusion criteria required by local law.
- ✕ 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study.
Where it's recruiting
Arizona
Scottsdale
California
Los Angeles · Sacramento
Connecticut
Hartford
District of Columbia
Washington D.C.
Florida
Gainesville · Lakeland · Tampa
Maryland
Baltimore
North Carolina
Chapel Hill · Durham
Pennsylvania
Philadelphia · Pittsburgh
Texas
Houston · Plano
Utah
Murray
Washington
Seattle
Wisconsin
Madison · Milwaukee
Source: ClinicalTrials.gov · NCT07166133 · last updated 2026-09-25